BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31485594)

  • 1. Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration.
    Wang K; Zhu TN; Zhao RJ
    Mol Med Rep; 2019 Oct; 20(4):3671-3678. PubMed ID: 31485594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients.
    Zhang K; Zhu T; Gao D; Zhang Y; Zhao Q; Liu S; Su T; Bernier M; Zhao R
    J Cancer Res Clin Oncol; 2014 Nov; 140(11):1913-26. PubMed ID: 24908328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of calpain‑1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNA.
    Xu C; Yu X; Zhu Y; Cai Z; Yu L; Lin Y; Yu H; Xue Z; Zhou L
    Oncol Rep; 2019 Jun; 41(6):3424-3434. PubMed ID: 31002357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
    Liu YC; Tsai JJ; Weng YS; Hsu FT
    Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine promotes tumorigenesis and cetuximab resistance via EGFR signaling activation in human colorectal cancer.
    Lu H; Zhang H; Weng ML; Zhang J; Jiang N; Cata JP; Ma D; Chen WK; Miao CH
    J Cell Physiol; 2021 Jun; 236(6):4445-4454. PubMed ID: 33184860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
    Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
    Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
    Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
    Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.
    Fiori JL; Zhu TN; O'Connell MP; Hoek KS; Indig FE; Frank BP; Morris C; Kole S; Hasskamp J; Elias G; Weeraratna AT; Bernier M
    Endocrinology; 2009 Jun; 150(6):2551-60. PubMed ID: 19213840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 13. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRR11 Promotes Proliferation and Migration of Colorectal Cancer through Activating the EGFR/ERK/AKT Pathway via Increasing CTHRC1.
    Ma H; Yang W; Wang X; Dai G
    Ann Clin Lab Sci; 2022 Jan; 52(1):86-94. PubMed ID: 35181621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLNa negatively regulated proliferation and metastasis in lung adenocarcinoma A549 cells via suppression of EGFR.
    Zhang Y; Zhu T; Liu J; Liu J; Gao D; Su T; Zhao R
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):164-170. PubMed ID: 29272322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
    Hu J; Li G; Liu L; Wang Y; Li X; Gong J
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
    Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
    Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 Inhibits Proliferation, Migration, and Invasion of Human Colorectal Cancer Cells by Suppressing Phosphorylation of Epidermal Growth Factor Receptor.
    Yang J; Zhu T; Zhao R; Gao D; Cui Y; Wang K; Guo Y
    Med Sci Monit; 2018 Jan; 24():332-341. PubMed ID: 29339715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.